Improved insulin sensitivity plays a key role in the management of NAFLD as the dysfunction of the insulin pathway causes the flow of FAs to the liver, increases TG synthesis and storage, inflammation, steatosis, and oxidative stress in the body [79]. The gene discussed is INS; the disease is steatosis.